New horizons in vascular biology and thrombosis: Highlights from EMVBM 2009

Thrombosis and Haemostasis

Volumn 104, Issue 3, 2010, Pages 421-423

  Mause, Sebastian F ^a   Weber, Christian ^a   Sampol, José ^b   Dignat George, Francoise ^b  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b AIX MARSEILLE UNIVERSITY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BILIVERDIN; BLOOD CLOTTING FACTOR 8; CALCITRIOL; CARBON MONOXIDE; CATALASE; GLYCOPROTEIN IB; GLYCOPROTEIN IB ALPHA; HEME OXYGENASE; HEME OXYGENASE 1; IRON; MAGNESIUM; METALLOPROTEINASE; MYOCARDIN; PHOSPHATE; PLASMIN; PLATELET DERIVED GROWTH FACTOR BB; PROTEINASE ACTIVATED RECEPTOR 1; PROTEINASE ACTIVATED RECEPTOR 2; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; RISTOCETIN; SERUM RESPONSE FACTOR; STROMAL CELL DERIVED FACTOR 1; THROMBOPLASTIN; VASCULOTROPIN; VON WILLEBRAND FACTOR; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ANGIOGENESIS; BLOOD CLOTTING; BLOOD VESSEL OCCLUSION; CELL INTERACTION; CHRONIC KIDNEY DISEASE; EDITORIAL; GENE DELETION; HUMAN; INFLAMMATION; MOLECULAR RECOGNITION; MOUSE MUTANT; PAIN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DEGRADATION; SHEAR STRESS; STIMULUS RESPONSE; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; THROMBOCYTOPENIC PURPURA; THROMBOSIS; TUMOR GROWTH; WOUND HEALING;

ANIMALS; BLOOD VESSELS; CELL-DERIVED MICROPARTICLES; CONGRESSES AS TOPIC; HEME OXYGENASE (DECYCLIZING); HUMANS; PHOSPHATES; STEM CELLS; THROMBOPLASTIN; THROMBOSIS; VON WILLEBRAND FACTOR;

EID: 77956640229     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH10-07-0485     Document Type: Editorial

References (24)

1. Furie B, Furie BC. Mechanisms of thrombus formation. New Engl J Med 2008; 359: 938-949.
2. Ruggeri ZM. Von Willebrand factor: looking back and looking forward. Thromb Haemost 2007; 98: 55-62.
3. Lenting PJ, et al. Regulation of von Willebrand factor-platelet interactions. Thromb Haemost 2010; 104: 449-455.
4. Gomez K, McVey JH. Tissue factor initiated blood coagulation. Front Biosci 2006; 11: 1349-1359. (Pubitemid 43253427)
5. Owens AP, 3rd, Mackman N. Tissue factor and thrombosis: The clot starts here. Thromb Haemost 2010; 104: 432-439.
6. Kretz CA, et al. Tissue factor and thrombosis models. Arterioscler Thromb Vasc Biol 2010; 30: 900-908.
7. Mackman N. The many faces of tissue factor. J Thromb Haemost 2009; 7 (Suppl 1): 136-139.
8. Ratajczak J, et al. Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication. Leukemia 2006; 20: 1487-1495. (Pubitemid 44264090)
9. Mause SF, et al. Platelet Microparticles Enhance the Vasoregenerative Potential of Angiogenic Early Outgrowth Cells After Vascular Injury. Circulation 2010; 122: 495-506.
10. Zernecke A, et al. Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Science Signal 2009; 200: ra81.
11. Leroyer AF, et al. Endothelial-derived microparticles: biological conveyors at the crossroad of inflammation, thrombosis and angiogenesis. Thromb Haemost 2010; 104: 456-463.
12. Xiao Q, et al. The mechanism of stem cell differentiation into smooth muscle cells. Thromb Haemost 2010; 104: 440-448.
13. Zernecke A, et al. SDF-1alpha/CXCR4 axis is instrumental in neointimal hyperplasia and recruitment of smooth muscle progenitor cells. Circulation Res 2005; 96: 784-791.
14. Hristov M, Weber C. Progenitor cell trafficking in the vascular wall. J Thromb Haemost 2009; 7 (Suppl 1): 31-34.
15. Iwata H, Sata M. Potential contribution of bone marrow-derived precursors to vascular repair and lesion formation: lessons from animal models of vascular diseases. Front Biosci 2007; 12: 4157-4167.
16. McDonald OG, Owens GK. Programming smooth muscle plasticity with chromatin dynamics. Circulation Res 2007; 100: 1428-1441. (Pubitemid 46834755)
17. Cordes KR, et al. miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature 2009; 460: 705-710.
18. Grochot-Przeczek A, et al. Heme oxygenase-1 in neovascularisation: A diabetic perspective. Thromb Haemost 2010; 104: 424-431.
19. Idriss NK, et al. Hemoxygenase-1 in cardiovascular disease. J Am Coll Cardiol 2008; 52: 971-978.
20. Bussolati B, et al. Bifunctional role for VEGF-induced heme oxygenase-1 in vivo: induction of angiogenesis and inhibition of leukocytic infiltration. Blood 2004; 103: 761-766. (Pubitemid 38129530)
21. Mause SF, Weber C. Intrusion through the fragile back door: immature plaque microvessels as entry portals for leukocytes and erythrocytes in atherosclerosis. J Am Coll Cardiol 2009; 53: 1528-1531.
22. Vanholder R, et al. Chronic kidney disease as cause of cardiovascular morbidity and mortality. Nephrol Dial Transplant 2005; 20: 1048-1056.
23. Lau WL, et al. Phosphate and Vascular Calcification: Emerging Role of the Sodium-Phosphate Cotransporter PiT-1. Thromb Haemost 2010; 104: 464-470.
24. Cannata-Andia JB, et al. Vascular calcifications: pathogenesis, management, and impact on clinical outcomes. J Am Soc Nephrol 2006; 17 (Suppl 3): S267-73.